Adolescent Depression Screening and Treatment in Mozambican Primary Care

Sponsor
Columbia University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05476237
Collaborator
National Institute of Mental Health (NIMH) (NIH)
68
4
2
12
17
1.4

Study Details

Study Description

Brief Summary

This is a cluster-randomized pilot trial of depression screening and treatment implementation at four Youth-friendly Health Services (YFHS) in primary care clinics, two in Maputo City and two in Maputo Province. YFHS will be stratified by urbanicity, such that one YFHS in Maputo City and one YFHS in Maputo Province will be randomized to interpersonal psychotherapy (IPT)-A and the other YFHS in each location with be randomized to treatment as usual (TAU).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Group Interpersonal Therapy for Adolescents (IPT-AG)
  • Behavioral: Treatment as Usual (TAU)
N/A

Detailed Description

Mental disorders are the leading cause of disability among adolescents worldwide, but only a very small minority, mostly in high-resource settings, have access to mental health care. The investigators' work is focused on understanding how to increase access to mental health care for adolescents in low-resource settings. In Mozambique, where this work is based, there are just 15 psychiatrists and 180 psychologists to serve its population of 29 million. In collaboration with local stakeholders, including governmental policymakers and primary care providers, the investigators developed a plan to implement care for adolescent depression in primary care settings. The investigators now aim to examine changes in adolescent depression and acceptability of primary care-based mental health services compared to treatment as usual.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Pilot Implementation of Depression Screening and Treatment for Adolescents in Mozambican Primary Care
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: TAU

Psychologists or PsyTechs in mental health services of primary care clinics will provide individual psychotherapy to depressed adolescents in the TAU arm. Local mental health professionals providing depression treatment in the TAU arm will not have been trained on IPT for adults or adolescents. Also, the two Ministry of Health psychologists trained as trainers of IPT-AG will not provide treatment in the TAU Arm.

Behavioral: Treatment as Usual (TAU)
Adolescents will be administered unstructured psychotherapy in individual sessions with a trained mental health specialist (i.e., psychologist or psychiatric technician).
Other Names:
  • TAU
  • Experimental: IPT-AG

    Group IPT-AG will be facilitated by the trained providers at each YFHS using the IPT-AG manual adapted to the Mozambican context. Adolescents will participate in 12 weekly sessions. The first and last sessions will be one-on-one with the provider. The first session is used for the participant and provider to develop a treatment plan and the last session is to prepare for treatment termination. All other sessions will be conducted in groups of 6-8 adolescents.

    Behavioral: Group Interpersonal Therapy for Adolescents (IPT-AG)
    IPT-AG is a ten session, group therapy for adolescents. Each group contains 6-8 adolescents who attend weekly sessions together. The goals of IPT-AG are: 1) to reduce depression symptoms, and 2) to improve interpersonal relationships. Another aim of the group format is to increase adolescents' experience with positive social interactions and to reduce social isolation.

    Outcome Measures

    Primary Outcome Measures

    1. PHQ-A results [6 months]

      The Patient Health Questionnaire (PHQ)-A is a 9-item severity measure of depression for adolescents adapted from the PHQ-9. Questions ask how often an adolescent has been bothered by different depression symptoms in the past week, and responses of "not at all," "several days," "more than half the days," and "nearly every day" are given scores of 0 to 3. A total score is calculated by summing the value of all items and ranges from 0 (better outcome) to 27 (worse outcome).

    2. IPT-AG Fidelity [6 months]

      The Group IPT-AG Fidelity Checklist is a 14-item scale that measures provider fidelity to group interpersonal therapy for adolescents. Providers are scored for superior (1), satisfactory (2), or needs improvement (3) adherence to each item on the checklist, which each represent and essential element of treatment (e.g., gives hope that depression is treatable, links depression to interpersonal problems). The score of the 14-items is averaged to compute the IPT-AG Fidelity rating (1=superior, 2=satisfactory, 3=needs improvement), with 1 indicating a better outcome.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 19 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Providers:

    2. IPT-AG Arm: YFHS staff will be included in the study if they (a) conduct screening for depression and/or group IPT-AG and (b) provide consent to participate in the study.

    3. TAU Arm: YFHS staff will be included in the study if they (a) provide referrals for adolescents suspected of having mental illness or seeking mental health services and (b) provide consent to participate in the study. Treatment providers (Psychiatric Technicians and psychologists) will be included in the study if they (a) treat adolescents referred from participating YFHS for depression and (b) provide consent to participate in the study.

    4. Patients: In both study arms, adolescents attending one of the four study YFHS will be included in the study if they:

    5. are between the ages of 12-19 years;

    6. screen positive for depression;

    7. provide informed consent (ages 16 -19) or if their guardian provides informed consent and they provide assent (if ages 12-15).

    8. Study centers: must be clinics that have YFHS.

    Exclusion Criteria:
    In both study arms, adolescents will be excluded if they:
    1. are unable to participate in treatment due to acute illness; and/or

    2. are unable to communicate sufficiently in Portuguese to answer inclusion questions.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centro de Saude Alto Mae Maputo Mozambique
    2 Centro de Saude Chamaculo Maputo Mozambique
    3 Centro de Saude Magoanine Tendas Maputo Mozambique
    4 Centro de Saude Primeiro de Maio Maputo Mozambique

    Sponsors and Collaborators

    • Columbia University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Kathryn Lovero, PhD, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kathryn L. Lovero, PhD, Assistant Professor of Sociomedical Sciences, Columbia University
    ClinicalTrials.gov Identifier:
    NCT05476237
    Other Study ID Numbers:
    • AAAT8351
    • K01MH120258
    First Posted:
    Jul 27, 2022
    Last Update Posted:
    Jul 27, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kathryn L. Lovero, PhD, Assistant Professor of Sociomedical Sciences, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2022